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KEY POINTS SUMMARY 
 
• Previous studies indicate a transient reduction in arterial function following 
large muscle group exercise, but the mechanisms are unknown.   
 
• Sympathetic nervous system activation may contribute to such reductions 
through direct effects in the artery wall, or because of decreases in arterial shear 
stress.  
 
• Administration of Prazosin (an α1-adrenoreceptor blocker) abolished the 
transient reduction in vascular function observed under placebo conditions 
following exercise. This effect could not be explained by drug-induced changes 
in arterial shear stress. 
 
• These results suggest that sympathetic vasoconstriction directly competes with 
endothelium-dependent dilator activity to influence post-exercise vascular 
function.  
 
• These findings have implications for understanding the stimuli responsible for 
exercise-induced adaptations in arterial function and health in humans.  
 
Word Count: 111 
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ABSTRACT 
Transient reduction in vascular function following systemic large muscle group exercise 
has previously been reported in humans. The mechanisms responsible are currently 
unknown.  We hypothesised that sympathetic nervous system activation, induced by 
cycle ergometer exercise, would contribute to post-exercise reductions in flow-mediated 
dilation (FMD).  Ten healthy male subjects (28±5years) undertook two 30 minute 
sessions of cycle exercise at 75% HRmax. Prior to exercise, individuals ingested either 
a placebo or an α1-adrenoreceptor blocker (Prazosin; 0.05mg.kg-1). Central 
hemodynamics, brachial artery shear rate (SR) and blood flow profiles were assessed 
throughout each exercise bout and in response to brachial artery FMD, measured prior 
to-, immediately after, and 60-minutes post-exercise.  Cycle exercise increased both 
mean and antegrade SR (P<0.001) with retrograde SR also elevated under both 
conditions  (P<0.001). Pre-exercise FMD was similar on both occasions, and 
significantly reduced (27%) immediately following exercise in the placebo condition (t-
test, P=0.03). In contrast, FMD increased (37%) immediately following exercise in the 
Prazosin condition (t-test, P=0.004, interaction effect P=0.01).  Post-exercise FMD 
remained different between conditions after correction for baseline diameters preceding 
cuff deflation and also post-deflation shear rate.  No differences in FMD or other 
variables were evident 60-minutes following recovery. Our results indicate that 
sympathetic vasoconstriction competes with endothelium-dependent dilator activity to 
determine post-exercise arterial function. These findings have implications for 
understanding the chronic impacts of interventions, such as exercise training, which 
affect both sympathetic activity and arterial shear stress. 
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ABBREVIATIONS 
 
ANOVA, analysis of variance;  
BF, blood flow;  
CO, cardiac output;  
FMD, flow-mediated dilation;  
HR, heart rate;  
LBNP; lower body negative pressure;  
LMM, linear mixed model;  
MAP, mean arterial pressure;  
SNS, sympathetic nervous system;  
SR, shear rate;  
SRAUC, shear rate area under curve;  
SV, stroke volume;  
TPRi, total peripheral resistance index. 
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INTRODUCTION 
Flow-mediated dilation (FMD) is a widely used method of assessment of vascular 
function that provides a surrogate index for arterial health (Takase et al., 1998; Gocke et 
al., 2003; Thijssen et al., 2011). Whilst the chronic effect of exercise training on FMD 
has been documented in a wide range of individuals (Maiorana et al., 2001; Green et al., 
2004; Watts et al., 2004; Tinken et al., 2008; Tinken et al., 2010; Birk et al., 2012), the 
impact of acute exercise on FMD responses is less clear (Dawson et al., 2013). The 
acute FMD response to large muscle mass exercise has therefore been a focus for recent 
studies, with a number of these documenting a transient reduction in FMD (Goel et al., 
2007; Dawson et al., 2008; Jones et al., 2010; Johnson et al., 2012b; Birk et al., 2013) 
which may be intensity-dependent (Johnson et al., 2012b; Birk et al., 2013). In addition, 
studies focusing on the impact of cycle ergometer exercise have demonstrated 
reductions in FMD in the upper limb vasculature (Jones et al., 2010; Johnson et al., 
2012b; Birk et al., 2013), which returns to baseline levels approximatetly 1-hr following 
the exercise bout, invoking the concept of “hormesis” (Padilla et al., 2011a).  The 
mechanisms responsible for this apparent reduction in FMD immediately following 
exercise are currently unknown, but may include oxidative stress, changes in blood 
pressure, arterial shear rate (in particular retrograde shear rate (Dawson et al., 2013)), 
and/or sympathetic nervous system (SNS) activation. 
 
We have previously published studies pertaining to the impact of distinct patterns of 
blood flow and shear rate on FMD responses (Thijssen et al., 2009b; Tinken et al., 
2009; Carter et al., 2013; Thijssen et al., 2014). Retrograde shear rate has been linked to 
a pro-atherogenic phenotype (Chappell et al., 1998; Ziegler et al., 1998; Hastings et al., 
2007; Laughlin et al., 2008; Conway et al., 2010) and reductions in arterial diameter 
(Carter et al., 2013) and FMD (Thijssen et al., 2009b; Tinken et al., 2009; Schreuder et 
al., 2014). Exercise which predominently activates the lower limbs, for example cycle 
ergometry, increases retrograde shear rate in the brachial artery (Green et al., 2002; 
Green et al., 2005; Thijssen et al., 2009a; Padilla et al., 2011b), particularly during the 
initial phase of exercise.  It was recently suggested by Padilla and colleagues that this 
may be linked to increased vasoconstrictor outflow (Padilla et al., 2010; Simmons et al., 
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2011).  However, the systemic impact of elevations in retrograde shear rate mediated by 
SNS activation during lower limb exercise has not been directly studied. 
 
Sympathetic nervous system activation, independent of exercise, has also been linked to 
reduction in FMD (Ghiadoni et al., 2000; Hijmering et al., 2002; Lind et al., 2002; 
Spieker et al., 2002; Dyson et al., 2006). Hijmering et al. utilised lower body negative 
pressure (LBNP: -20mmHg) to increase sympathetic outflow and demonstrated an acute 
reduction in FMD that was abolished by intra-arterial infusion of phentolamine 
(Hijmering et al., 2002). Whilst other studies could not replicate LBNP-induced 
reductions in FMD (Dyson et al., 2006), reduced FMD responses have been observed 
following mental stress (Ghiadoni et al., 2000; Spieker et al., 2002) and cold pressor 
tests (Lind et al., 2002; Dyson et al., 2006). We recently demonstrated that LBNP of -
35mmHg reduced brachial artery FMD (Thijssen et al., 2014) and that this response was 
mitigated when the increase in retrograde shear rate induced by LBNP was abolished by 
the simultaneous application of a heating stimulus.  We concluded that SNS activation 
induced by LBNP may cause a reduction in FMD which is, at least partly, due to 
changes in arterial shear rate patterns. This experiment was performed in resting 
subjects. 
 
The impact of exercise-mediated SNS activation on brachial artery FMD remains 
unclear, as does the extent to which any such impact can be attributed to changes in 
arterial (especially retrograde) shear rate. We therefore hypothesised that SNS 
activation as a result of cycle exercise would contribute to reductions in post-exercise 
FMD, an effect mediated by changes in brachial artery shear rate. 
 
 
METHODS 
Ethical Approval 
All study procedures were approved by the University of British Columbia (Okanagen) 
institutional ethics committee and adhered to the Declaration of Helsinki. All 
participants provided written, informed consent before participating in the study. 
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Participants 
Ten healthy, recreationally active male subjects (age: 28±5 years, height: 1.91±0.40m, 
weight: 80.1±14.7kg) volunteered for the study. Subjects were normotensive (SBP<130 
and DBP<85mmHg), medication free and non-smokers, with no previous history of 
cardiovascular disease/s.  
 
Experimental Design 
Participants were required to report to our laboratory on two occasions. All participants 
arrived in a fasted state (>6hrs) (Thijssen et al., 2011), having avoided strenuous 
exercise, alcohol and caffeine for a minimum of 8hrs prior to testing. Time of day of 
testing sessions was kept consistent for each participant with a minimum of 48 hrs and 
maximum of 7 days between sessions. Ninety minutes before commencing the 
experimental protocol participants orally ingested a capsule containing either an α1-
adrenoreceptor blocker (Prazosin; 0.05mg.kg-1 body mass) or a placebo (empty capsule) 
and were instructed to lie down. This dosage of Prazosin provides ~80% alpha blockade 
and has previously been utilised in research studies similar in nature (Jones et al., 2011; 
Lewis et al., 2013; Lewis et al., 2014).  Following 90-minutes rest, individuals were 
placed on a semi-supine bike (Lode Ergometer, Lode, Groningen, Netherlands) and 
their arm was extended and secured ~80° from the torso. An initial assessment of 
brachial artery endothelial function, using the flow-mediated dilation technique 
(Thijssen et al., 2011), was then conducted. Each subject then completed 30 minutes of 
cycle exercise at 75% max heart rate (mean workloads were 161±16 W in the placebo 
condition and 140±20 W in the Prazosin condition). During every 5-minute period of 
exercise, a 1-minute measurement of brachial artery shear rate and blood flow was 
recorded, whilst blood pressure parameters were recorded continuously (Finometer Pro, 
Finapres Medical Systems, Amsterdam, Netherlands). Previous data from our 
laboratory indicates that the CV associated with repeated Finometer measures collected 
at rest is ~5% (Lewis et al., 2015) and others have validated model flow approaches 
during exercise (Sugawara et al., 2003). Post-exercise FMD was then measured 
immediately, and 60 minutes following, exercise cessation. The order of the conditions 
i.e. Prazosin vs placebo, was randomised.  
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Experimental Measurements 
Central heamodynamics 
Changes in mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), stroke 
volume (SV) and total peripheral resistance index (TPRi) were continuously measured 
using a Finometer PRO (Finapres Medical Systems, Netherlands), with data exported 
into PowerLab (Labchart 7, AD Instruments, Sydney, Australia). 
 
Assessment of brachial artery endothelial function 
After extending the arm to an ~80° angle from the torso, a rapid inflation/deflation 
pneumatic cuff (D.E. Hokanson, Bellevue, WA) was placed on the forearm, distal to the 
olecranon process. With the use of a 10-15 MHz multi-frequency-linear array probe 
attached to a high-resolution ultrasound machine (T3200; Terason, Burlington, MA), a 
B-mode image of the brachial artery was obtained. Following optimal acquisition of an 
image and a one-minute baseline recording of artery diameter and velocity, the forearm 
cuffs were inflated to 220 mmHg for 5 minutes. Recordings of diameter and velocity 
continued 30 second prior to cuff deflation and continued for 3 minutes thereafter, in 
accordance with previous studies (Woodman et al., 2001). This procedure was repeated 
immediately, and 60-minutes following, cycle ergometer exercise. 
 
Brachial artery diameter and blood flow/shear rate analysis 
Brachial artery diameter and velocity were analysed using a custom-designed edge-
detection and wall-tracking software, which is largely independent of investigator bias 
(Woodman et al., 2001), described in detail elsewhere (Black et al., 2008; Thijssen et 
al., 2011). Diameter measurements collected using this software are more reliable and 
observer-independent than manual methods and reduce observer error, whilst 
possessing an intra-observer coefficient of variation of 6.7% (Woodman et al., 2001). 
Continuous (30 Hz) diameter and velocity data were used to calculate blood flow (BF) 
(the product of lumen cross-sectional are and Doppler velocity). Shear rate (SR) was 
calculated as 4 times mean blood velocity divided by vessel diameter. Finally, FMD 
was calculated in absolute (mm) and relative (%) terms as the increase from resting 
baseline diameter to peak diameter, described elsewhere (Black et al., 2008; Thijssen et 
al., 2011). 
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Statistics 
Statistical analysis was performed using SPSS 22.0 (SPSS, Chicago, IL). All data are 
reported as mean ± SD unless otherwise stated and the statistical significance was 
assumed at P<0.05. A two-way repeated measures analysis of variance (ANOVA) was 
used to compare mean SR & BF across ‘time’ (9 time points throughout- and post- 
exercise) and between ‘conditions’ (Placebo & Prazosin). Similar analysis was 
performed on each of the following variables: antegrade SR & BF, retrograde SR & BF, 
MAP, HR, SV, CO, TPRi, vascular conductance and brachial artery diameter.  
Additional two-way repeated measures ANOVA was completed for the assessment 
across time (pre, post & post 60) and condition (Placebo & Prazosin) for baseline 
brachial artery diameter, change in diameter during the FMD, FMD%, and FMD SR 
area under curve (SRAUC). Post-hoc analysis was performed using the least significant 
difference (LSD) methods. Finally, we analysed the effects of time (Pre, Post & Post60) 
and condition (Placebo & Prazosin) for FMD variables, on the change in logarithmically 
transformed diameter using a linear mixed model (LMM) using baseline arterial 
diameter and SRAUC as covariates (Atkinson et al., 2013). This approach accounts for 
any changes in FMD that may be related to baseline diameter or SR differences between 
conditions. 
 
RESULTS 
There were no differences in pre-exercise measures of brachial artery diameter, SR, 
FMD%, or SRAUC between the two testing conditions (placebo vs. alpha) (Table 1, all 
P>0.05).  
 
Exercise heamodynamics 
Mean arterial pressure increased in response to exercise in both the placebo and 
Prazosin conditions (time P<0.001, Figure 1). Whilst higher values were evident under 
the placebo condition during exercise, these differences were statistically insignificant 
(P=0.06 for condition; P=0.12 interaction effect). HR was significantly elevated 
throughout exercise, with elevations higher under the Prazosin condition (condition 
effect P=0.04, Figure 1). Stroke volume was also elevated throughout exercise, with 
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higher values under the placebo condition (P=0.03) and no interaction effect (interaction 
effect P=0.10). Cardiac output and TPRi did not differ between conditions (Figure 1). 
 
Brachial artery shear rate and blood flow 
Mean SR was elevated significantly in both conditions during exercise (P<0.001) with a 
significant condition*time interaction (P=0.01). Post hoc tests revealed significantly 
higher mean SR at the 5 minute exercise time point under the Prazosin condition 
(P=0.02, Figure 2), with no significant differences at any other exercise time point. 
 
Antegrade SR increased in both conditions during exercise (time P<0.001), with a 
significant condition*time interaction (P=0.03). Similar to mean SR, post hoc tests 
demonstrated a significantly higher antegrade SR at the 5 minute exercise time point in 
the Prazosin condition. Retrograde SR also increased significantly in both conditions 
(time both P<0.001), although no difference was evident in this increase between the 
conditions (interaction effect P=0.08, Figure 2).  
 
Both mean and antegrade BF increased with exercise in both conditions (both P<0.001) 
with both demonstrating a significant condition*time interaction (P=0.02 and P=0.01, 
respectively). Post hoc tests revealed that at the 5 and 10 minute exercise time points, 
both mean and antegrade flows were higher in the Prazosin condition. Finally, 
retrograde BF increased under both conditions (P<0.001), with no condition or 
interaction effects apparent (P=0.22 and P=0.14 respectively).  
 
Vascular conductance increased in both conditions (P<0.001) but this increase was not 
significant between the two conditions (condition effect P=0.24, Figure 3). Finally, 
brachial artery diameter increased during the exercise session in both conditions 
(P<0.001) but this effect was not different between the two conditions (condition effect 
P=0.80, Figure 3). 
 
FMD Parameters 
Two-way ANOVA performed on baseline brachial artery diameter revealed a 
significant time effect (P=0.04), but no condition or interaction effects (Table 1).  A 
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significant time*condition interaction was evident for FMD (%) (P=0.01, Figure 4). 
Post-hoc tests indicated a significant FMD reduction immediately following the 30 
minute exercise intervention (P=0.03) under the placebo condition, whereas an increase 
in FMD was observed with Prazosin (P=0.004, Figure 4). In terms of the post cuff 
deflation SR stimulus to FMD [FMD SRAUC (103·s-1)], Prazosin was associated with 
elevated values both before and after exercise (condition effect P < 0.01). However, 
when corrected for changes in both diameter and SRAUC [CORRECTED FMD (%), 
Table 1], the interaction effect for FMD remained (P<0.01).  
 
 
DISCUSSION 
In keeping with several previous studies examining large muscle group exercise (Goel 
et al., 2007; Dawson et al., 2008; Jones et al., 2010; Johnson et al., 2012b; Birk et al., 
2013), we observed a transient post-exercise reduction in brachial artery FMD 
following 30 minutes of cycle ergometer exercise in the present study. This effect was 
abolished by the ingestion of Prazosin, a specific α1-adrenoceptor blocker, suggesting 
that exercise-induced increases in SNS activation contribute to the acute effects of 
exercise on arterial function in vivo.   
 
Whilst an acute impact of exercise on arterial function has been previously reported 
(Goel et al., 2007; Dawson et al., 2008; Jones et al., 2010; Johnson et al., 2012b; Birk et 
al., 2013), these studies have not fully addressed the mechanisms responsible. The 
impact of SNS activation on FMD may be due to direct interactions between 
neurotransmitters and endothelium-dependent vasodilators (Kolo et al., 2004) or 
secondary impacts of sympathetic vasoconstriction on arterial SR during exercise, or 
both. In this context, we recently demonstrated that FMD reduction during LBNP was 
ameliorated by applying a forearm heating stimulus that normalised the brachial artery 
retrograde shear rate (Thijssen et al., 2014). These findings  indicated that changes in 
FMD may, at least partly, result from LBNP effects on retrograde shear rather than 
direct impacts on endothelium-mediated dilation per se. In the present study, the impact 
of Prazosin on FMD cannot be ascribed to impacts of this drug on SR responses during 
exercise, as it was associated with small but significant increases in retrograde shear 
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across the exercise period. These findings therefore infer that the α1-blockade may have 
direct impacts on the nitrtic oxide-dilator pathway and FMD response during large 
muscle group lower limb exercise. Indeed, a number of studies in animals have 
indicated that nitric oxide interacts with noradrenaline, thereby directly modifying 
arterial vasoactivity (Vo et al., 1991; Chowdhary & Townend, 1999; Zanzinger, 1999; 
Kolo et al., 2004). Our data suggests that a balance exists between SNS-mediated 
vasoconstriction and endothelium-dependent dilation, with large muscle group lower 
limb exercise associated with a transient increase in systemic SNS activation, and 
consequent reduction in FMD. Prazosin-induced blockade of α1-adrenoceptors altered 
this balance in favour of nitric oxide-mediated vasodilation and consequent increased 
FMD, as observed immediately post-exercise in the present experiment. 
 
By virtue of its α-blocking action, Prazosin is a vasodilator and it is possible that the 
stimulus to brachial arterial dilation following cuff deflation during the FMD tests was 
affected by this drug.  Indeed, directly measured SRAUC following cuff defalation was 
higher in the Prazosin condition, although no interaction effect existed for SRAUC 
between the conditions and the magnitude of change in SR after exercise was similar 
between the conditions (15.87 to 30.34 s-1 ∙103: 90% increase; 20.15 to 37.42 s-1 ∙103: a 
86% increase).  Furthermore, the significant impact of Prazosin on FMD% persisted 
after we corrected for differences in the SR stimulus pre- and post-exercise. It seems 
unlikely that the effect of Prazosin on FMD that we observed can be fully or even 
largely explained by effects on the SR stimulus per se. 
 
Vascular function and FMD can be modulated by inflammation and oxidative stress and 
several studies have reported improvements in FMD following treatments that 
ameliorate oxidation and inflammation (Ellis et al., 2000; Silvestro et al., 2002; Donato 
et al., 2010; Johnson et al., 2012a; Wray et al., 2012; Johnson et al., 2013). 
Improvements in FMD following the ingestion of anti-oxidants have been observed in 
the elderly (Donato et al., 2010; Johnson et al., 2012a), patients with hypertension 
(Plantinga et al., 2007), peripheral artery disease (Silvestro et al., 2002) and heart 
failure (Ellis et al., 2000). Conversely, studies in healthy individuals have typically not 
demonstrated increases in FMD with oral antioxidants administration (Richardson et al., 
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2007; Donato et al., 2010), although Johnson and colleages suggested that vitamin C 
supplementation in the presence of increased retrograde SR induced by either cuff 
placement (Johnson et al., 2013) or cycle exercise (Johnson et al., 2012a), can enhance 
FMD responses. We cannot exclude the possibility that the exercise performed in our 
study had impacts on inflammatory or oxidative factors.  However, the acute impact of 
Prazosin is specific to α1-adrenoceptor blockade and we are unaware of any direct 
effects of this agent on inflammation  or oxidative stress.  The complete reversal in 
FMD we observed with Prazosin strongly implies that interaction between SNS 
activation and nitric oxide  plays a role in the acute impact of exercise on arterial 
function in humans. 
 
It is an important limitation of our study that no direct assessment of sympathetic 
nervous system activation was undertaken.  Whilst iIt is not technically possible to 
perform muscle sympathetic nerve activity (MSNA) assessments from the common 
peroneal nerve during cycle exercise, and upper limb MSNA assessments are also 
challenging to maintain at higher cycle exercise intensities.  , Whilst ist is possible that 
any impact of whole body exercise would be greater during the immediate post-exercise 
period, than at latter time points (eg 1 hr), and some human evidence exists to suppoort 
this contention (Cleroux et al., 1992), there is also evidence that muscle sympathetic 
nerve activity is lower following large muscle mass exercise (Halliwill et al., 1996; 
Kulics et al., 1999) and this question has not been resolved in the literature.  Another 
limitation is that Prazosin provides specific α1-receptor blockade and, therefore, we 
cannot exclude the possibility that differential β-adrenoceptor mediated dilation or α2-
mediated vasoconstriction occurred in the downstream microvasculature in our study. 
Some studies suggest that functional sympatholysis is mainly due to blunting of α2-
adrenoceptor mediated vasoconstriction (Wray et al., 2004) although both α1- and α2-
adrenergic receptor mediated vasoconstriction are blunted in contracting human skeletal 
muscle (Rosenmeier et al., 2003). Our findings indicate that, at the level of the conduit 
arteries, α1-blockade impacts on FMD and this effect is not due to changes in arterial 
shear stress (as a result of downstream vascular effects), since the impact of Prazosin on 
flows and shear were directionally opposite to those that might enhance FMD. 
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Nonetheless, there remains a possibility that increases in retrograde shear with Prazosin 
may be due to greater α2-mediated constriction when α1-receptors are blocked, and 
multiple blockade with non-specific α- and β-blockade could address possibility in 
future studies. 
 
A final limitation of our study relates to differences between the conditions in exercise 
intensity.  We exercised subjects to a target HR (75% HR max), due mainly to our 
previous study (Birk et al., 2013) which indicated that exercise at ~70%HRmax resulted 
in a significant decrease in FMD post-cycling. We didn’t anticipate that Prazosin would 
induce differences in workload of ~20W between the conditions. This could 
theoretically contribute to the differences we observed in post-exercise FMD.  However, 
in Birk et al. (Birk et al., 2013), cycling performed at lower workloads resulted in a 
decrease in FMD, whereas in our study post-exercise FMD increased when Prazosin 
was administered. Furthermore, a correlation performed between differences between 
conditions in workload and exercise-impact on FMD, revealed no relationship (r=0.18, 
P=0.62). We suggest that, whilst distinct workloads may have contributed to some 
extent to the FMD differences between conditions, it seems that a primary impact of 
Prazosin on nitric oxide mediated dilator function predominated.  
 
Conclusions. Our findings suggest that changes in vascular function following cycle 
exercise reflect a balance between sympathetically-driven vasoconstriction and nitric 
oxide-mediated vasodilation. The acute impairment on FMD observed post-exercise in 
the current study suggests that cycle exercise, at the intensity used in this study, 
transiently alters this balance in favour of SNS-mediated vasoconstriction. When taken 
in context with previous studies utilising LBNP, the findings of the present study 
suggest that a direct interaction between noradrenaline and endothelium-dependent 
dilators, and/or SNS-mediated changes in SR patterns, can both influence artery 
function in vivo.  The contribution of these direct and indirect pathways may differ 
according to which stimulus of SNS activation is adopted: previous studies suggest that 
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LBNP contributes to FMD changes via shear stress related mechanisms, whereas our 
current results cannot be explained via this secondary impact.   
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Table 1. Baseline (pre-exercise) and post exercise FMD, shear rate and blood flow, on each day. 
 PLACEBO PRAZOSIN 2-way ANOVA 
 Pre Post 
Post 
60mins 
Pre Post 
Post 
60mins 
Condition Time Time*Condition 
Baseline diameter 
(mm) 
4.43±0.28 4.78±0.66 4.41±0.33 4.44±0.28 4.57±0.34 4.50±0.26 0.55 0.04 0.11 
Change in 
diameter during 
FMD (mm) 
0.22±0.07 0.15±0.05 0.25±0.07 0.21±0.05 0.29±0.08 0.26±0.13 0.07 0.16 0.01 
FMD (%) 5.09±1.65 3.22±1.13 5.78±1.69 4.70±1.18 6.32±1.91 5.76±2.82 0.06 0.11 0.01 
FMD SRAUC 
(103·s-1) 
15.87±9.05 30.34±9.30 17.71±4.36 20.15±8.36 37.42±11.15 26.21±8.12 0.01 <0.001 0.41 
CORRECTED 
FMD (%) 
2.10±0.56 1.69±0.62 2.47±0.63 2.02±0.48 2.56±0.86 2.43±1.13 0.19 0.10 <0.01 
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FIGURE LEGENDS 
 
FIGURE 1 Mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), 
cardiac output (CO) and total peripheral resistance index (TPRi) across 30 minutes of 
cycle exercise at 75%HR max. Grey squares denote ‘Placebo’ condition and black 
squares denote ‘Prazosin’ condition. Error bars represent SE. Statistical significance 
assumed at P≤0.05 and # representing statistical significance between conditions. (NB: 
subjects were exercised at a target HR of 75%HRmax, resulting in mean workloads of 
161±16 W in the placebo condition and 140±20 W in the Prazosin condition) 
 
FIGURE 2 Mean, antegrade and retrograde shear rate (SR) comparisons across 30 
minutes of cycle exercise at 75%HR max under ‘Placebo’ (grey squares) and ‘Prazosin’ 
(black squares). Error bars represent SE. Statistical significance assumed at P≤0.05 and 
# represents statistical significance between conditions. (NB: subjects were exercised at 
a target HR of 75%HRmax, resulting in mean workloads of 161±16 W in the placebo 
condition and 140±20 W in the Prazosin condition) 
 
FIGURE 3 Blood flow, conductance, brachial artery velocity and arterial diameter 
across 30 minutes of cycle exercise at 75%HR max under ‘Placebo’ (grey squares) and 
‘Prazosin’ (black squares). Error bars represent SE. Statistical significance assumed at 
P≤0.05 and # represents statistical significance between conditions. (NB: subjects were 
exercised at a target HR of 75%HRmax, resulting in mean workloads of 161±16 W in 
the placebo condition and 140±20 W in the Prazosin condition) 
 
FIGURE 4  Brachial artery flow-mediated dilation (FMD) prior to, immediately post 
and 60 minutes following 30 minutes cycle exercise at 75%HRmax in the (A) Placebo 
condition (grey bars) and (B) Prazosin condition (black bars). Error bars represent SE. 
Statistical significance assumed at P≤0.05 and * represents statistical significance from 
‘Pre’ value. (NB: subjects were exercised at a target HR of 75%HRmax, resulting in 
mean workloads of 161±16 W in the placebo condition and 140±20 W in the Prazosin 
condition) 
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